Dr. Panagiotis Roussos studies the genetic mechanisms through which risk genetic variants increase vulnerability for neuropsychiatric diseases, including schizophrenia, bipolar disorder and Alzheimer’s disease. To identify these mechanisms he uses advanced biostatistical methods to integrate high-dimensional data, such as genomic, epigenomic and transcriptomic data. Among his many accolades, Dr. Roussos recently received the Presidential Early Career Awards for Scientists and Engineers from President Obama, and is the Principal Investigator of three grants funded by the NIA, NIMH and VA. Click here for his lab website.